Respecto al efecto de la L-carnitina para atenuar la produccin de cido lctico, Ransone y Lefavi (1997), no observaron este efecto al estudiar a 26 corredores que realizaron pruebas de 400 m o 1500 m, en donde la ingesta oral de 2 gr de L-carnitina por da no produjo variaciones significativas en los niveles de cido lctico medidos 1, 3 y 5 minutos luego de finalizar el esfuerzo (Ransone & Lefavi 1997)
GLP-3 (Reta) Research Applications GIP, GLP-1 and glucagon receptor binding and cAMP-accumulation assays in cells co-expressing the three receptors, where GLP-3 (Reta) is the standard reference triple agonist
Its important to be mindful of diet quality given the reductions in caloric intake that accompany GLP-1-based medications with an emphasis on calcium, iron, and protein, noted Garvey
Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association
Adverse events were classified by severity as mild (easily tolerated, causing minimal discomfort, and not interfering with everyday activities), moderate (causes sufficient discomfort and interferes with normal everyday activities), or severe (prevents normal everyday activities)